Monofer (Ferric derisomaltose Vials) 100 mg/ml

MONOFER (ferric derisomaltose) is an iron replacement therapy available in vials for intravenous use. It provides iron supplementation for conditions requiring increased iron levels. This 100 mg/ml formulation is designed for efficient iron delivery in clinical settings.

Strength

100 mg/ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Pierre Fabre Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ferric derisomaltose is used to treat iron deficiency when oral supplements are ineffective or unsuitable. It helps restore iron levels in patients with anemia or low iron stores. This therapy is often prescribed for those undergoing hemodialysis or with chronic kidney disease. It may also support iron replenishment after significant blood loss.

Side Effects

After administration, ferric derisomaltose works to replenish iron stores in the body. Patients may notice improved energy levels as iron levels normalize. Some individuals report reduced fatigue following treatment. The effects vary based on individual iron deficiency severity.

Precautions & Warnings

MONOFER should be handled by healthcare professionals in a clinical setting. Patients with known allergies to iron products should inform their provider. Monitoring for infusion reactions is recommended during administration. Keep out of reach of children and store at controlled room temperature.

Avoid Interactions

Ferric derisomaltose may interact with oral iron supplements, reducing their absorption. Certain medications, like tetracyclines or thyroid hormones, may have altered effectiveness when taken with iron therapy. Always inform your healthcare provider about all medications being used. Alcohol consumption may affect iron absorption and should be discussed with a doctor.

Frequently Asked Questions

It is used to treat iron deficiency anemia when oral iron supplements are not suitable or effective.

It is given as an intravenous infusion by a healthcare professional in a clinical setting.

Oral iron supplements may interfere with absorption; consult your healthcare provider before combining therapies.

Possible side effects include nausea, headache, or infusion-related reactions like dizziness.

Iron therapy should only be used during pregnancy if prescribed by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.